Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

Prediction of hemorrhagic transformation in patients with mild atrial fibrillation-associated stroke treated with early anticoagulation: post hoc analysis of the Triple AXEL Trial.

Lee SH, Hong KS, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH, Kang DW, Kang HG, Yu KH, Kwon SU.

Clin Neurol Neurosurg. 2018 Sep 9;174:156-162. doi: 10.1016/j.clineuro.2018.08.026. [Epub ahead of print]

PMID:
30243187
2.

Familial Risk of Appendicitis: A Nationwide Population Study.

Li HM, Yeh LR, Huang YK, Hsieh MY, Yu KH, Kuo CF.

J Pediatr. 2018 Sep 5. pii: S0022-3476(18)31046-1. doi: 10.1016/j.jpeds.2018.07.071. [Epub ahead of print]

PMID:
30195556
3.

MiR-93 blocks STAT3 to alleviate hepatic injury after ischemia-reperfusion.

Xiong L, Yu KH, Zhen SQ.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5295-5304. doi: 10.26355/eurrev_201808_15729.

PMID:
30178854
4.

A Cloud-Based Metabolite and Chemical Prioritization System for the Biology/Disease-Driven Human Proteome Project.

Yu KH, Lee TM, Chen YJ, Ré C, Kou SC, Chiang JH, Snyder M, Kohane IS.

J Proteome Res. 2018 Aug 21. doi: 10.1021/acs.jproteome.8b00378. [Epub ahead of print]

PMID:
30094994
5.

Urate-lowering treatment and risk of total joint replacement in patients with gout.

Kuo CF, Chou IJ, See LC, Chen JS, Yu KH, Luo SF, Hsieh AH, Zhang W, Doherty M.

Rheumatology (Oxford). 2018 Jul 27. doi: 10.1093/rheumatology/key212. [Epub ahead of print]

PMID:
30060176
6.

Trajectory Groups of 24-Hour Systolic Blood Pressure After Acute Ischemic Stroke and Recurrent Vascular Events.

Kim BJ, Cho YJ, Hong KS, Lee J, Kim JT, Choi KH, Park TH, Park SS, Park JM, Kang K, Lee SJ, Kim JG, Cha JK, Kim DH, Nah HW, Lee BC, Yu KH, Oh MS, Kim DE, Ryu WS, Choi JC, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Hong JH, Lee JS, Lee J, Han MK, Gorelick PB, Bae HJ.

Stroke. 2018 Jul 16. pii: STROKEAHA.118.021117. doi: 10.1161/STROKEAHA.118.021117. [Epub ahead of print]

PMID:
30012819
7.

Education for the future.

Pietrzak B, Ward A, Cheung MK, Schwendimann BA, Mollaoglu G, Duong MT, Ulltveit-Moe N, Allareddy V, Dutton-Regester K, Zhang J, Scult MA, Naz S, Singh PC, Yan HY, Isaacson K, Dennis AF, Al-Humaidan EI, Beardsley FR, Lo C, Sood P, Jones T, Nieuwenhuis R, Ali BA, Yu KH, Arthur PK, Kumar B, Chen A, Buschke F, Cingl L, Zaidi SS, O'Mullane AP, Coetzee V, Konstantinides N.

Science. 2018 Jun 29;360(6396):1409-1412. doi: 10.1126/science.aau3877. No abstract available.

PMID:
29954971
8.

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.

Glassman DC, Palmaira RL, Covington CM, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O'Reilly EM, Yu KH.

BMC Cancer. 2018 Jun 27;18(1):693. doi: 10.1186/s12885-018-4605-1.

9.

Nationwide Estimation of Eligibility for Endovascular Thrombectomy Based on the DAWN Trial.

Lee KJ, Kim BJ, Kim DE, Ryu WS, Han MK, Kim JT, Choi KH, Cho KH, Cha JK, Kim DH, Nah HW, Park JM, Kang K, Lee SJ, Kim JG, Oh MS, Yu KH, Lee BC, Hong KS, Cho YJ, Park TH, Lee KB, Lee J, Lee JS, Lee J, Bae HJ; Clinical Research Collaboration for Stroke in Korea (CRCS-K) Investigators.

J Stroke. 2018 May;20(2):277-279. doi: 10.5853/jos.2018.00836. Epub 2018 May 31. No abstract available.

10.

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.

Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, Palmaira RLD, Javed AA, Huynh JC, Johnson M, Arora K, Robine N, Shah M, Sanghvi R, Goetz AB, Lowder CY, Martello L, Driehuis E, LeComte N, Askan G, Iacobuzio-Donahue CA, Clevers H, Wood LD, Hruban RH, Thompson E, Aguirre AJ, Wolpin BM, Sasson A, Kim J, Wu M, Bucobo JC, Allen P, Sejpal DV, Nealon W, Sullivan JD, Winter JM, Gimotty PA, Grem JL, DiMaio DJ, Buscaglia JM, Grandgenett PM, Brody JR, Hollingsworth MA, O'Kane GM, Notta F, Kim E, Crawford JM, Devoe C, Ocean A, Wolfgang CL, Yu KH, Li E, Vakoc CR, Hubert B, Fischer SE, Wilson JM, Moffitt R, Knox J, Krasnitz A, Gallinger S, Tuveson DA.

Cancer Discov. 2018 Sep;8(9):1112-1129. doi: 10.1158/2159-8290.CD-18-0349. Epub 2018 May 31.

PMID:
29853643
11.

Effects of glycemic variability and hyperglycemia in acute ischemic stroke on post-stroke cognitive impairments.

Lim JS, Kim C, Oh MS, Lee JH, Jung S, Jang MU, Lee SH, Kim YJ, Kim Y, Suh SW, Lee BC, Yu KH.

J Diabetes Complications. 2018 Jul;32(7):682-687. doi: 10.1016/j.jdiacomp.2018.02.006. Epub 2018 Mar 29.

PMID:
29793824
12.

Cerebral Oxygenation as a Monitoring Parameter for Mortality During Venoarterial Extracorporeal Membrane Oxygenation.

Kim HS, Ha SO, Yu KH, Oh MS, Park S, Lee SH, Han SJ, Kim HS, Chang IB, Ahn JH.

ASAIO J. 2018 May 15. doi: 10.1097/MAT.0000000000000827. [Epub ahead of print]

PMID:
29768283
13.

Timing and risk of mood disorders requiring psychotropics in long-term survivors of adult cancers: A nationwide cohort study.

Huang WK, Juang YY, Chung CC, Chang SH, Chang JW, Lin YC, Wang HM, Chang HK, Chen JS, Tsai CS, Yu KH, Kuo CF, See LC.

J Affect Disord. 2018 Aug 15;236:80-87. doi: 10.1016/j.jad.2018.04.107. Epub 2018 Apr 25.

PMID:
29723766
14.

Author Correction: Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.

Jang YK, Kim HJ, Lee JS, Kim YJ, Kim KW, Kim Y, Jang H, Lee J, Lee JM, Kim SJ, Yu KH, Charidimou A, Werring DJ, Kim ST, Na DL, Seo SW.

Sci Rep. 2018 Mar 21;8(1):5196. doi: 10.1038/s41598-018-23383-6.

15.

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.

Hurwitz H, Van Cutsem E, Bendell J, Hidalgo M, Li CP, Salvo MG, Macarulla T, Sahai V, Sama A, Greeno E, Yu KH, Verslype C, Dawkins F, Walker C, Clark J, O'Reilly EM.

Invest New Drugs. 2018 Aug;36(4):683-695. doi: 10.1007/s10637-018-0580-2. Epub 2018 Mar 6.

PMID:
29508247
16.

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.

Lowery MA, Wong W, Jordan EJ, Lee JW, Kemel Y, Vijai J, Mandelker D, Zehir A, Capanu M, Salo-Mullen E, Arnold AG, Yu KH, Varghese AM, Kelsen DP, Brenner R, Kaufmann E, Ravichandran V, Mukherjee S, Berger MF, Hyman DM, Klimstra DS, Abou-Alfa GK, Tjan C, Covington C, Maynard H, Allen PJ, Askan G, Leach SD, Iacobuzio-Donahue CA, Robson ME, Offit K, Stadler ZK, O'Reilly EM.

J Natl Cancer Inst. 2018 Feb 28. doi: 10.1093/jnci/djy024. [Epub ahead of print]

PMID:
29506128
17.

Systematic Protein Prioritization for Targeted Proteomics Studies through Literature Mining.

Yu KH, Lee TM, Wang CS, Chen YJ, Ré C, Kou SC, Chiang JH, Kohane IS, Snyder M.

J Proteome Res. 2018 Apr 6;17(4):1383-1396. doi: 10.1021/acs.jproteome.7b00772. Epub 2018 Mar 15.

PMID:
29505266
18.

Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?

Jordan EJ, Lowery MA, Basturk O, Allen PJ, Yu KH, Tabar V, Beal K, Reidy DL, Yamada Y, Janjigian Y, Abou-Alfa GK, O'Reilly EM.

Clin Colorectal Cancer. 2018 Jun;17(2):e315-e321. doi: 10.1016/j.clcc.2018.01.009. Epub 2018 Feb 7.

PMID:
29496399
19.

Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.

Mier-Hicks A, Raj M, Do RK, Yu KH, Lowery MA, Varghese A, O'Reilly EM.

Clin Colorectal Cancer. 2018 Jun;17(2):121-128. doi: 10.1016/j.clcc.2018.01.008. Epub 2018 Jan 31.

PMID:
29477452
21.

EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles.

Tsai WH, Yu KH, Huang YC, Lee CI.

Int J Nanomedicine. 2018 Feb 9;13:903-916. doi: 10.2147/IJN.S148305. eCollection 2018.

22.

A Methodological Perspective on the Longitudinal Cognitive Change after Stroke.

Lim JS, Noh M, Kim BJ, Han MK, Kim S, Jang MS, Lee Y, Ha ID, Yu KH, Lee BC, Kang Y, Lee J, Bae HJ.

Dement Geriatr Cogn Disord. 2017;44(5-6):311-319. doi: 10.1159/000484477. Epub 2018 Jan 26.

PMID:
29393166
23.

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

Hu ZI, Shia J, Stadler ZK, Varghese AM, Capanu M, Salo-Mullen E, Lowery MA, Diaz LA Jr, Mandelker D, Yu KH, Zervoudakis A, Kelsen DP, Iacobuzio-Donahue CA, Klimstra DS, Saltz LB, Sahin IH, O'Reilly EM.

Clin Cancer Res. 2018 Mar 15;24(6):1326-1336. doi: 10.1158/1078-0432.CCR-17-3099. Epub 2018 Jan 24.

PMID:
29367431
24.

An in Vitro Study on the Effect of Combined Treatment with Photodynamic and Chemical Therapies on Candida albicans.

Hsieh YH, Zhang JH, Chuang WC, Yu KH, Huang XB, Lee YC, Lee CI.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E337. doi: 10.3390/ijms19020337.

25.

Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.

Yu KH, Chen DY, Chen JH, Chen SY, Chen SM, Cheng TT, Hsieh SC, Hsieh TY, Hsu PF, Kuo CF, Kuo MC, Lam HC, Lee IT, Liang TH, Lin HY, Lin SC, Tsai WP, Tsay GJ, Wei JC, Yang CH, Tsai WC.

Int J Rheum Dis. 2018 Apr;21(4):772-787. doi: 10.1111/1756-185X.13266. Epub 2018 Jan 24. Review.

PMID:
29363262
26.

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.

O'Reilly EM, Lee JW, Lowery MA, Capanu M, Stadler ZK, Moore MJ, Dhani N, Kindler HL, Estrella H, Maynard H, Golan T, Segal A, Salo-Mullen EE, Yu KH, Epstein AS, Segal M, Brenner R, Do RK, Chen AP, Tang LH, Kelsen DP.

Cancer. 2018 Apr 1;124(7):1374-1382. doi: 10.1002/cncr.31218. Epub 2018 Jan 16.

PMID:
29338080
27.

Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review.

Hicks AM, DeRosa A, Raj M, Do R, Yu KH, Lowery MA, Varghese A, O'Reilly EM.

Clin Colorectal Cancer. 2018 Jun;17(2):e207-e216. doi: 10.1016/j.clcc.2017.12.001. Epub 2017 Dec 12. Review.

PMID:
29306522
28.

Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by D-Galactose in an Aging Rats Model.

Chen NY, Liu CW, Lin W, Ding Y, Bian ZY, Huang L, Huang H, Yu KH, Chen SB, Sun Y, Wei L, Peng JH, Pan SL.

Evid Based Complement Alternat Med. 2017;2017:4757520. doi: 10.1155/2017/4757520. Epub 2017 Oct 19.

29.

EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.

Lung RW, Hau PM, Yu KH, Yip KY, Tong JH, Chak WP, Chan AW, Lam KH, Lo AK, Tin EK, Chau SL, Pang JC, Kwan JS, Busson P, Young LS, Yap LF, Tsao SW, To KF, Lo KW.

J Pathol. 2018 Apr;244(4):394-407. doi: 10.1002/path.5018. Epub 2018 Feb 16.

30.

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.

Lowery MA, Kelsen DP, Capanu M, Smith SC, Lee JW, Stadler ZK, Moore MJ, Kindler HL, Golan T, Segal A, Maynard H, Hollywood E, Moynahan M, Salo-Mullen EE, Do RKG, Chen AP, Yu KH, Tang LH, O'Reilly EM.

Eur J Cancer. 2018 Jan;89:19-26. doi: 10.1016/j.ejca.2017.11.004. Epub 2017 Dec 8.

PMID:
29223478
31.

Benefits of Intraluminal Agarose Stents during End-to-End Intestinal Anastomosis in New Zealand White Rabbits.

Kuo WY, Huang HC, Huang SW, Yu KH, Cheng FP, Wang JH, Wu JT.

Comp Med. 2017 Dec 1;67(6):504-507.

32.

Predictive Value of Pulse Pressure in Acute Ischemic Stroke for Future Major Vascular Events.

Lee KJ, Kim BJ, Han MK, Kim JT, Cho KH, Shin DI, Yeo MJ, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Park JM, Kang K, Lee SJ, Oh MS, Yu KH, Lee BC, Hong KS, Cho YJ, Choi JC, Sohn SI, Hong JH, Park TH, Park SS, Kwon JH, Kim WJ, Lee J, Lee JS, Lee J, Gorelick PB, Bae HJ; CRCS-5 Investigators.

Stroke. 2018 Jan;49(1):46-53. doi: 10.1161/STROKEAHA.117.019582. Epub 2017 Dec 4.

PMID:
29203686
33.

Risk of autism spectrum disorder in children born to mothers with systemic lupus erythematosus and rheumatoid arthritis in Taiwan.

Tsai PH, Yu KH, Chou IJ, Luo SF, Tseng WY, Huang LH, Kuo CF.

Joint Bone Spine. 2017 Nov 26. pii: S1297-319X(17)30195-1. doi: 10.1016/j.jbspin.2017.11.005. [Epub ahead of print]

PMID:
29183859
34.

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.

Jang YK, Kim HJ, Lee JS, Kim YJ, Kim KW, Kim Y, Jang H, Lee J, Lee JM, Kim SJ, Yu KH, Charidimou A, Werring DJ, Kim ST, Na DL, Seo SW.

Sci Rep. 2017 Nov 22;7(1):15984. doi: 10.1038/s41598-017-16298-1. Erratum in: Sci Rep. 2018 Mar 21;8(1):5196.

35.

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results.

O'Reilly EM, Roach J, Miller P, Yu KH, Tjan C, Rosano M, Krause S, Avery W, Wolf J, Flaherty K, Nix D, Ryan DP.

Oncologist. 2017 Dec;22(12):1429-e139. doi: 10.1634/theoncologist.2017-0472. Epub 2017 Nov 20.

36.

Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.

Yu KH, Berry GJ, Rubin DL, Ré C, Altman RB, Snyder M.

Cell Syst. 2017 Dec 27;5(6):620-627.e3. doi: 10.1016/j.cels.2017.10.014. Epub 2017 Nov 15.

PMID:
29153840
37.

Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis.

Fang YF, Chen YF, Chung TT, See LC, Yu KH, Luo SF, Kuo CF, Lai JH.

Oncotarget. 2017 Jul 6;8(46):80461-80471. doi: 10.18632/oncotarget.19057. eCollection 2017 Oct 6.

38.

Promoting human rights through science.

Segal L, Chow RD, Kumar B, Nguyen J, Yu KH, Chen J, Polat EO, Porter KE, Kelly-Irving M, Bimpe I, Winter KA, Zeng R, Ahmed M, Saalman DR, James JI, Kosinski M, White ER, Oda FS, Bretscher H, Hamel P, Negi S, Jawaid A.

Science. 2017 Oct 6;358(6359):34-37. doi: 10.1126/science.aaq1083. No abstract available.

PMID:
28983033
39.

One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis.

Park HK, Kim BJ, Han MK, Park JM, Kang K, Lee SJ, Kim JG, Cha JK, Kim DH, Nah HW, Park TH, Park SS, Lee KB, Lee J, Hong KS, Cho YJ, Lee BC, Yu KH, Oh MS, Kim JT, Choi KH, Kim DE, Ryu WS, Choi JC, Johansson S, Lee SJ, Lee WH, Lee JS, Lee J, Bae HJ; CRCS-K Investigators.

Stroke. 2017 Nov;48(11):2991-2998. doi: 10.1161/STROKEAHA.117.018045. Epub 2017 Oct 3.

PMID:
28974634
40.

Omics AnalySIs System for PRecision Oncology (OASISPRO): A Web-based Omics Analysis Tool for Clinical Phenotype Prediction.

Yu KH, Fitzpatrick MR, Pappas L, Chan W, Kung J, Snyder M.

Bioinformatics. 2017 Sep 12. doi: 10.1093/bioinformatics/btx572. [Epub ahead of print]

PMID:
28968749
41.

START: a system for flexible analysis of hundreds of genomic signal tracks in few lines of SQL-like queries.

Zhu X, Zhang Q, Ho ED, Yu KH, Liu C, Huang TH, Cheng AS, Kao B, Lo E, Yip KY.

BMC Genomics. 2017 Sep 22;18(1):749. doi: 10.1186/s12864-017-4071-1.

42.

Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.

Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH, Kang DW, Kang HG, Yu KH; Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group.

JAMA Neurol. 2017 Oct 1;74(10):1206-1215. doi: 10.1001/jamaneurol.2017.2161.

PMID:
28892526
43.

Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.

Yu KH, Yu CY, Fang YF.

Int J Rheum Dis. 2017 Sep;20(9):1057-1071. doi: 10.1111/1756-185X.13143. Epub 2017 Aug 31. Review.

PMID:
28857441
44.

A comprehensive analysis of the association of common variants of ABCG2 with gout.

Yu KH, Chang PY, Chang SC, Wu-Chou YH, Wu LA, Chen DP, Lo FS, Lu JJ.

Sci Rep. 2017 Aug 30;7(1):9988. doi: 10.1038/s41598-017-10196-2.

45.

A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.

Lowery MA, Yu KH, Kelsen DP, Harding JJ, Bomalaski JS, Glassman DC, Covington CM, Brenner R, Hollywood E, Barba A, Johnston A, Liu KC, Feng X, Capanu M, Abou-Alfa GK, O'Reilly EM.

Cancer. 2017 Dec 1;123(23):4556-4565. doi: 10.1002/cncr.30897. Epub 2017 Aug 18.

PMID:
28832976
46.

Familial Aggregation and Heritability of Congenital Heart Defects.

Kuo CF, Lin YS, Chang SH, Chou IJ, Luo SF, See LC, Yu KH, Huang LS, Chu PH.

Circ J. 2017 Dec 25;82(1):232-238. doi: 10.1253/circj.CJ-17-0250. Epub 2017 Aug 19.

47.

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.

Lowery MA, Jordan EJ, Basturk O, Ptashkin RN, Zehir A, Berger MF, Leach T, Herbst B, Askan G, Maynard H, Glassman D, Covington C, Schultz N, Abou-Alfa GK, Harding JJ, Klimstra DS, Hechtman JF, Hyman DM, Allen PJ, Jarnagin WR, Balachandran VP, Varghese AM, Schattner MA, Yu KH, Saltz LB, Solit DB, Iacobuzio-Donahue CA, Leach SD, O'Reilly EM.

Clin Cancer Res. 2017 Oct 15;23(20):6094-6100. doi: 10.1158/1078-0432.CCR-17-0899. Epub 2017 Jul 28.

PMID:
28754816
48.

Pancreas adenocarcinoma: novel therapeutics.

Krantz BA, Yu KH, O'Reilly EM.

Chin Clin Oncol. 2017 Jun;6(3):30. doi: 10.21037/cco.2017.06.14.

49.

Preclinical models of pancreatic ductal adenocarcinoma.

Krempley BD, Yu KH.

Chin Clin Oncol. 2017 Jun;6(3):25. doi: 10.21037/cco.2017.06.15. Review.

50.

Development of a sedation protocol using orally administered tiletamine-zolazepam-acepromazine in free-roaming dogs.

Huang HC, Huang SW, Yu KH, Wang JH, Wu JT.

Vet Anaesth Analg. 2017 Sep;44(5):1035-1041. doi: 10.1016/j.vaa.2017.03.003. Epub 2017 Apr 14.

PMID:
28693970

Supplemental Content

Support Center